Meanwhile, FO/Se treatment resulted in higher levels of plasma IFN-γ and IL-2 together with lower IL-6 in doxorubicin-treated tumor-bearing mice than does doxorubicin treatment alone. The gene discussed is IFNG; the disease is neoplasm.